High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis
- PMID: 1348364
- PMCID: PMC48805
- DOI: 10.1073/pnas.89.7.3070
High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis
Abstract
Exposure of human ovarian tumor cell lines to cisplatin led to development of cell lines that exhibited increasing degrees of drug resistance, which were closely correlated with increase of the levels of cellular glutathione. Cell lines were obtained that showed 30- to 1000-fold increases in resistance; these cells also had strikingly increased (13- to 50-fold) levels of glutathione as compared with the drug-sensitive cells of origin. These levels of resistance to cisplatin and the cellular glutathione levels are substantially greater than previously reported. Very high cisplatin resistance was associated with enhanced expression of mRNAs for gamma-glutamylcysteine synthetase and gamma-glutamyl transpeptidase; immunoblots showed increase of gamma-glutamylcysteine synthetase but not of glutathione synthetase. Glutathione S-transferase activity was unaffected, as determined with chlorodinitrobenzene as a substrate. These studies suggest the potential value of examining regulation of glutathione synthesis as an indicator of clinical prognosis. The highly resistant cell lines are proving useful for studying the multiple mechanisms by which tumor cells acquire drug- and radiation-resistance.
Similar articles
-
Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines.Cancer Res. 1995 Oct 1;55(19):4367-74. Cancer Res. 1995. PMID: 7671249
-
Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines.Biochem Pharmacol. 1996 Jul 12;52(1):21-7. doi: 10.1016/0006-2952(96)00131-1. Biochem Pharmacol. 1996. PMID: 8678904
-
Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.Cancer Res. 1993 Nov 1;53(21):5225-32. Cancer Res. 1993. PMID: 8106143
-
Importance of glutathione and associated enzymes in drug response.Oncol Res. 1997;9(6-7):295-302. Oncol Res. 1997. PMID: 9406235 Review.
-
Regulation of cellular glutathione.Am J Physiol. 1989 Oct;257(4 Pt 1):L163-73. doi: 10.1152/ajplung.1989.257.4.L163. Am J Physiol. 1989. PMID: 2572174 Review.
Cited by
-
The Novel Zinc Finger Protein 587B Gene, ZNF587B, Regulates Cell Proliferation and Metastasis in Ovarian Cancer Cells in vivo and in vitro.Cancer Manag Res. 2020 Jun 26;12:5119-5130. doi: 10.2147/CMAR.S252347. eCollection 2020. Cancer Manag Res. 2020. PMID: 32617020 Free PMC article.
-
Mechanistic Nanotherapeutic Approach Based on siRNA-Mediated DJ-1 Protein Suppression for Platinum-Resistant Ovarian Cancer.Mol Pharm. 2016 Jun 6;13(6):2070-83. doi: 10.1021/acs.molpharmaceut.6b00205. Epub 2016 May 26. Mol Pharm. 2016. PMID: 27170529 Free PMC article.
-
Research progress on branched-chain amino acid aminotransferases.Front Genet. 2023 Nov 6;14:1233669. doi: 10.3389/fgene.2023.1233669. eCollection 2023. Front Genet. 2023. PMID: 38028625 Free PMC article. Review.
-
Electron transfer-based combination therapy of cisplatin with tetramethyl-p-phenylenediamine for ovarian, cervical, and lung cancers.Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10175-80. doi: 10.1073/pnas.1203451109. Epub 2012 Jun 8. Proc Natl Acad Sci U S A. 2012. PMID: 22685209 Free PMC article.
-
APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells.Cell Death Dis. 2015 Jun 18;6(6):e1794. doi: 10.1038/cddis.2015.143. Cell Death Dis. 2015. PMID: 26086967 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials